G. Gianfranceschi

发表

Apolipoprotein AIMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant.

G. Franceschini, G. Vecchio, G. Gianfranceschi, 1985, The Journal of biological chemistry.

AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1985, American journal of human genetics.

Efficacy of cholestyramine does not vary when taken before or during meals.

G. Gianfranceschi, C. Sirtori, F. Pazzucconi, 1991, Atherosclerosis.

Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1995, Atherosclerosis.

Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients.

G. Gianfranceschi, C. Sirtori, E. Tremoli, 1986, The American journal of clinical nutrition.

Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1981, Metabolism: clinical and experimental.

Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers.

G. Davı̀, G. Gianfranceschi, E. Tremoli, 1995, The American journal of clinical nutrition.

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.

V. Vaccarino, G. Franceschini, G. Gianfranceschi, 1989, Arteriosclerosis.

Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.

G. Gianfranceschi, E. Tremoli, G. Rovati, 1985, Biochemical pharmacology.

Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1990, Atherosclerosis.

Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population.

J. Werba, G. Franceschini, G. Gianfranceschi, 1993, Atherosclerosis.

Pravastatin effectively lowers LDL-cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1994 .

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.

G. Franceschini, G. Vecchio, G. Gianfranceschi, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Decreased high density lipoprotein-cholesterol levels in male patients with transient ischemic attacks.

I. Gritti, G. Gianfranceschi, C. Sirtori, 1979, Atherosclerosis.

Lipid effects of celiprolol, a new cardioselective β‐blocker, versus propranolol

V. Vaccarino, G. Gianfranceschi, C. Sirtori, 1989 .

Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1990, Atherosclerosis.

Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.

J. Werba, G. Franceschini, G. Gianfranceschi, 1993, Metabolism: clinical and experimental.

Apoprotein Changes Following Treatments with Hypolipidemic Drugs

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1980 .

Microsomal enzyme inducers raise plasma high‐density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemia

J. Werba, G. Franceschini, G. Gianfranceschi, 1995, Clinical pharmacology and therapeutics.

Non‐invasive assessment of unstimulated forearm arterial compliance in human subjects. Impaired vasoreactivity in hypercholesterolaemia

G. Gianfranceschi, C. Sirtori, D. Baldassarre, 1995, European journal of clinical investigation.

Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia

G. Franceschini, G. Gianfranceschi, C. Sirtori, 2006, European Journal of Clinical Pharmacology.

Omega-3 fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1991, Metabolism: clinical and experimental.

Effect of coenzyme a infusions on postprandial triglyceride metabolism and PAI-1 levels in patients with moderate hypertriglyceridemia

G. Gianfranceschi, C. Sirtori, E. Tremoli, 1992 .

Differential effect of unsaturated oils and butter on blood glucose and insulin response to carbohydrate in normal volunteers.

G. Gianfranceschi, C. Sirtori, M. Porrini, 1992, European Journal of Clinical Nutrition.

Oral polyunsaturated phosphatidylcholine reduces platelet lipid and cholesterol contents in healthy volunteers

G. Gianfranceschi, C. Sirtori, E. Tremoli, 1985, Lipids.

Lipoprotein structure in male subjects during in vivo lipolysis: effect of an anti-lipolytic treatment with acipimox.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1993, Journal of lipid research.

Lipoprotein structure in male subjects vivo lipolysis: effect of an anti-lipolytic with acipimox during in treatment

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1993 .

Predictability of low‐density lipoprotein levels during apheretic treatment of hypercholesterolemia

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1991, European journal of clinical investigation.

Pantethine Treatment in Type III Hyperlipoproteinemia

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1987 .

Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.

G. Gianfranceschi, C. Sirtori, E. Tremoli, 1983, Atherosclerosis.

Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis.

G. Gianfranceschi, C. Sirtori, F. Bernini, 1981, Atherosclerosis.

Correlation between plasma levels of fenofibrate and lipoprotein changes in hyperlipidaemic patients

E. Bosisio, G. Gianfranceschi, C. Sirtori, 2004, European Journal of Clinical Pharmacology.

Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma-free fatty acids in normal subjects.

G. Gianfranceschi, C. Sirtori, E. Tremoli, 1984, Drug-nutrient interactions.

MICROPOROUS CHOLESTYRAMINE IN SUSPENSION FORM

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1982, The Lancet.

Pharmacological studies on tiadenol in type IV patients. Evidence for a mechanism of action different from other lipid-lowering drugs.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1981, Atherosclerosis.

Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal.

V. Vaccarino, G. Franceschini, G. Gianfranceschi, 1988, Atherosclerosis.

Activity profile of gemfibrozil on the major plasma lipoprotein parameters

V. Vaccarino, G. Franceschini, G. Gianfranceschi, 1992, European Journal of Epidemiology.

Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.

V. Vaccarino, G. Franceschini, G. Gianfranceschi, 1989, The Journal of laboratory and clinical medicine.

Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1985, Artery.

Lipid profile and anticardiolipin antibodies in rheumatoid arthritis.

G. Franceschini, G. Gianfranceschi, M. Cutolo, 1995, Clinical and experimental rheumatology.

Prolonged retention of doubly labeled phosphatidylcholine in human plasma and erythrocytes after oral administration

V. Vaccarino, G. Gianfranceschi, C. Sirtori, 1992, Lipids.

Metformin Improves Peripheral Vascular Flow in Nonhyperlipidemic Patients with Arterial Disease

E. Bosisio, G. Franceschini, G. Gianfranceschi, 1984, Journal of cardiovascular pharmacology.

Increased postprandial lipemia in Apo A-IMilano carriers.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction.

G. Franceschini, G. Vecchio, G. Gianfranceschi, 1995, Atherosclerosis.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1993 .

Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1992, The American journal of clinical nutrition.

Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1987, The Journal of laboratory and clinical medicine.

Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma.

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1990, The Journal of biological chemistry.

Both gestodene and desogestrel containing oral contraceptives reduce antipyrine clearance by impairing microsomal oxidative metabolism

G. Franceschini, G. Gianfranceschi, C. Sirtori, 1990 .